Cord blood-derived early outgrowth endothelial progenitor cells

Microvascular Research

Volumn 79, Issue 3, 2010, Pages 174-177

  Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angeiogenesis; Cord blood; Endothelial progenitors; Vasculogenesis

Indexed keywords

CD34 ANTIGEN; HLA ANTIGEN;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL GROWTH; CELL PROLIFERATION; ENDOTHELIUM CELL; ENDOTHELIUM PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD;

ANIMALS; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; ENDOTHELIAL CELLS; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE;

EID: 77952089854     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.01.008     Document Type: Article

References (50)

1. Almici C., Carlo-Stella C., Wagner J.E., et al. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation. Bone Marrow Transplant. 1997, 19:1079-1984.
2. Asahara T., Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol. 2004, 287:C572-C579.
3. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:965-967.
4. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
5. Chen H.K., Hung H.F., Shyu K.G., et al. Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction. Eur. J. Clin. Invest. 2005, 35:677-686.
6. Civin C.I., Strauss L.C., Brovall C., et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antigody raised against KG-1a. J. Immunol. 1984, 133:157-165.
7. Crisa L., Cirulli V., Smith K.A., et al. Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 1999, 94:3928-3940.
8. D'Amore P.A., Thompson R.W. Mechanisms of angiogenesis. Annu. Rev. Physiol. 1987, 49:453-464.
9. Das H., George J.C., Joseph M., et al. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One 2009, 4:e7325.
10. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The FMS-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255:989-991.
11. Finney, M.R., Fanning, L.R., Joseph, M.E. et al., 2010. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. Cytotherapy. 12, 67-78.
12. Flamme I., Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 1992, 116:435-439.
13. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1:27-31.
14. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 1989, 321:1174-1178.
15. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
16. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1584-1595.
17. Hur J., Yoon C.H., Kim H.S. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
18. Ichim T.E., Solano F., Brenes R., et al. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod. Biomed. Online 2008, 16:898-905.
19. Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 1999, 103:1231-1236.
20. Ito A., Nomura S., Hirota S., Suda J., Suda T., Kitamura Y. Enhanced expression of CD34 messenger RNA by developing endothelial cells of mice. Lab. Invest. 1995, 72:532-538.
21. Jang J.H., Kim S.K., Choi J.E., et al. Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. Acta Pharmacol. Sin. 2007, 28:367-374.
22. Kalka C., Iwaguro H., Masuda H., et al. Generation of differentiated endothelial cells from mononuclear cells of human umbilical cord blood. Circulation 1999, 100(Suppl. I):I-749.
23. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3422-3427.
24. Katoh O., Tauchi H., Kawaishi K., Kimura A., Satou Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 1995, 55:5687-5692.
25. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
26. Kim B.O., Tian H., Prasongsukarn K., et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005, 112(Suppl.). I-96-I-104.
27. Kim S.W., Han H., Chae G.T., et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006, 24:1620-1626.
28. Kondo T., Hayashi M., Takeshita K., et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1442-1447.
29. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000, 105:71-77.
30. Ma N., Stamm C., Kaminski A., et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 2005, 66:45-54.
31. Ma N., Ladilov Y., Moebius J.M., et al. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells. Cardiovasc. Res. 2006, 71:158-169.
32. Mayani H., Lansdorp P.M. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994, 83:2410-2417.
33. Millauer B., Wizigmann-Voos S., Schnurch H., et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846.
34. Murohara T., Horowitz J.R., Silver M., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998, 97:99-107.
35. Murohara T., Ikeda H., Duan J., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000, 105:1527-1536.
36. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J. Clin. Invest. 1982, 70:1324-1328.
37. Nieda M., Nicol A., Denning-Kendall P., et al. Endothelial cell precursors are normal components of human umbilical cord blood. Br. J. Haematol. 1997, 98:775-777.
38. Nishikawa S., et al. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 1998, 125:1747-1757.
39. Risau W., Sariola H., Zerwes H.G., et al. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development 1988, 102:471-478.
40. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74.
41. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
42. Shintani S., Murohara T., Ikeda H., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001, 103:897-903.
43. Taguchi A., Soma T., Tanaka H., et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 2004, 114:330-338.
44. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
45. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:E1-E7.
46. Vaziri H., Dragowska W., Allsopp R.C., et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9857-9860.
47. Weiss M., Orkin S.H. In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J. Clin. Invest. 1996, 97:591-595.
48. Yamaguchi T.P., Dumont D.J., Conlon R.A., Breitman M.L., Rossant J. flk-1, and flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 1993, 118:489-498.
49. Yano M., Iwama A., Nishio H., et al. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood 1997, 89:4317-4326.
50. Yi C., Xia W., Zheng Y., et al. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps. J. Surg. Res. 2006, 135:100-106.